The Microbiome Solutions group is focused on accelerating the translation of today’s promising microbiome science into tomorrow’s health solutions. The group believes that fostering cooperation and partnerships within the scientific, medical and entrepreneurial communities will be essential to effectively translate promising microbiome science into solutions that address the root cause of disease and promote health. The group combines its pioneering expertise in the microbiome with the drug discovery, product development and commercialization know-how of a leading global biopharmaceutical company. This team was previously recognized as the Janssen Human Microbiome Institute (JHMI).
